Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Apr:66:254-61.
doi: 10.1016/j.fct.2014.01.048. Epub 2014 Feb 3.

Species and gender differences in the carcinogenic activity of trimethylolpropane triacrylate in rats and mice

Inok Surh  1 , Deepa B Rao  2 , Mark F Cesta  3 , Charles D Hébert  4 , Jill F Mann  4 , Helen Cunny  3 , Grace E Kissling  3 , David Malarkey  3 , Rajendra S Chhabra  3
Affiliations

Species and gender differences in the carcinogenic activity of trimethylolpropane triacrylate in rats and mice

Inok Surh et al. Food Chem Toxicol. 2014 Apr.

Abstract

Trimethylolpropane triacrylate (TMPTA) is a multifunctional monomer with industrial applications. To determine the carcinogenic potential, male and female F344/N rats and B6C3F1/N mice were administered TMPTA (0, 0.3, 1.0, or 3.0mg/kg) in acetone dermally for 2 years. There were no differences in the body weights and survival in the treated animals compared to controls. Nonneoplastic skin lesions at the site of application included epidermal hyperplasia and hyperkeratosis in both rats and mice. There were no incidences of tumors at the site of application in rats and mice. Rare malignant liver neoplasms were observed in female mice that included hepatoblastoma in the 0.3 and 3.0mg/kg groups, and hepatocholangiocarcinoma in the 1.0 and 3.0mg/kg groups. The incidences of uterine stromal polyp and stromal polyp or stromal sarcoma (combined) in female mice occurred with positive trends and the incidences were significantly increased in the 3.0mg/kg group. A marginal increase in the incidences of malignant mesothelioma in male rats may have been related to TMPTA treatment. In conclusion, our studies show that TMPTA is a dermal irritant in both rats and mice of either sex. Increased incidences of tumor formation were observed in female mice and male rats.

Keywords: Carcinogenicity; Liver; Skin; Trimethylolpropane triacrylate; Uterine.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

The authors declare no conflicts of interest.

Figures

Fig. 1
Fig. 1
Malignant mesothelioma in the mesentery of a male F344/N rat administered 3.0 mg/kg TMPTA in the 2-year dermal study. The malignant mesothelioma is papillary and consists of one or more layers of neoplastic mesothelial cells. H&E.
Fig. 2
Fig. 2
Hepatoblastoma in the liver of a male B6C3F1/N mouse administered 3.0 mg/kg TMPTA in the 2-year dermal study. An expansile mass within the hepatic parenchyma is composed of small, deeply basophilic neoplastic cells and contains blood-filled cystic spaces. H&E.
Fig. 3
Fig. 3
Hepatocholangiocarcinoma in the liver of a male B6C3F1/N mouse administered 1.0 mg/kg TMPTA in the 2-year dermal study. The neoplasm contains both neoplastic hepatocytes and neoplastic bile duct epithelial cells with necrotic and cystic areas. H&E.
Fig. 4
Fig. 4
Stromal polyp in the uterus of a female B6C3F1/N mouse administered 3.0 mg/kg TMPTA in the 2-year dermal study. The polyp is a pedunculated mass that protrudes into the lumen and contains marked cellular pleomorphism. H&E.
See this image and copyright information in PMC

References

    1. Adams ET, Auerbach S, Blackshear PE, Bradley A, Gruebbel MM, Little PB, Malarkey D, Maronpot R, McKay JS, Miller RA, Moore RR, Morrison JP, Nyska A, Ramot Y, Rao D, Suttie A, Wells MY, Willson GA, Elmore SA. Proceedings of the 2010 national toxicology program satellite symposium. Toxicol. Pathol. 2011;39:240–266. - PMC - PubMed
    1. Andrews LS, Clary JJ. Review of the toxicity of multifunctional acrylates. J. Toxicol. Environ. Health. 1986;19:149–164. - PubMed
    1. Attanoos RL, Gibbs AR. Pathology of malignant mesothelioma. Histopathology. 1997;30:403–418. - PubMed
    1. Bach U, Hailey JR, Hill GD, Kaufmann W, Latimer KS, Malarkey DE, Maronpot RM, Miller RA, Moore RR, Morrison JP, Nolte T, Rinke M, Rittinghausen S, Suttie AW, Travlos GS, Vahle JL, Willson GA, Elmore SA. Proceedings of the 2009 national toxicology program satellite symposium. Toxicol. Pathol. 2010;38:9–36. - PMC - PubMed
    1. Bailer AJ, Portier CJ. Effects of treatment-induced mortality and tumor-induced mortality on tests for carcinogenicity in small samples. Biometrics. 1988;44:417–431. - PubMed